In conclusion, our present study revealed the tumorigenic role of SNHG12 in ccRCC, and we also uncovered a novel mechanism that SNHG12 competitively binds with miR‐30a‐3p and up‐regulates the expression of downstream oncogenes, RUNX2, IGF‐1R and WNT2. This evidence concerns the gene RUNX2 and nonpapillary renal cell carcinoma.